PARP knockout and treatment with PARP inhibitors can effectively reduce the inflammatory response caused by microglial activation and neurodegeneration in AD (Stoica et al., 2014; Mao and Zhang, 2021). This evidence concerns the gene PARP1 and Alzheimer disease.